相似文献
1
Treatment of premalignancy: prevention of lymphoma in radiation leukemia virus-inoculated mice by cyclosporin A and immunotoxin.
Proc Natl Acad Sci U S A. 1992 Jan 15;89(2):728-32. doi: 10.1073/pnas.89.2.728.
2
Prophylactic intervention in RadLV-induced lymphomagenesis with an anti-IL-4 monoclonal antibody.
J Immunother. 1997 Jul;20(4):287-91. doi: 10.1097/00002371-199707000-00005.
3
Induction of IL-4 secretion by the radiation leukemia virus (RadLV): role in autocrine growth stimulation of RadLV infected pre-leukemic cells.
Int J Cancer. 1992 Feb 1;50(3):481-5. doi: 10.1002/ijc.2910500325.
4
Radiation leukemia virus (RadLV)-induced leukemogenesis is associated with an increased number and activity of thymic macrophages.
Int J Cancer. 1991 Jul 30;48(6):924-30. doi: 10.1002/ijc.2910480621.
5
[Interaction of radiation-induced preleukemia cells and bone marrow grafts in C57BL/Ka mice].
C R Seances Soc Biol Fil. 1987;181(1):82-7.
6
Thymic nurse cells account for the thymus dependency of preleukemic cells in mice after inoculation of radiation leukemia virus.
Leuk Res. 1983;7(5):575-80. doi: 10.1016/0145-2126(83)90128-5.
7
Clonal dominance of RadLV-induced lymphomas.
Leuk Res. 1995 Dec;19(12):971-6. doi: 10.1016/0145-2126(95)00079-8.
8
Prophylactic intervention in radiation-leukemia-virus-induced murine lymphoma by the biological response modifier polysaccharide K.
Cancer Immunol Immunother. 1995 Dec;41(6):389-96. doi: 10.1007/BF01526559.
9
Quantitation, in vitro propagation, and characterization of preleukemic cells induced by radiation leukemia virus.
Cancer Res. 1991 Apr 15;51(8):2179-84.
10
Clonal analysis of radiation leukemia virus-induced leukemic and preleukemic murine cells.
Cancer Res. 1987 Dec 15;47(24 Pt 1):6590-4.
引用本文的文献
1
Augmenting the Efficacy of Immunotoxins and Other Targeted Protein Toxins by Endosomal Escape Enhancers.
Toxins (Basel). 2016 Jul 1;8(7):200. doi: 10.3390/toxins8070200.
2
Immunotoxins constructed with ribosome-inactivating proteins and their enhancers: a lethal cocktail with tumor specific efficacy.
Curr Pharm Des. 2014;20(42):6584-643. doi: 10.2174/1381612820666140826153913.
3
Enhancement of immunotoxin activity using chemical and biological reagents.
Br J Cancer. 1997;75(9):1347-55. doi: 10.1038/bjc.1997.228.
4
Prophylactic intervention in radiation-leukemia-virus-induced murine lymphoma by the biological response modifier polysaccharide K.
Cancer Immunol Immunother. 1995 Dec;41(6):389-96. doi: 10.1007/BF01526559.
5
Combined use of an immunotoxin and cyclosporine to prevent both activated and quiescent peripheral blood T cells from producing type 1 human immunodeficiency virus.
Proc Natl Acad Sci U S A. 1993 Feb 15;90(4):1411-5. doi: 10.1073/pnas.90.4.1411.
6
CD2-mediated autocrine growth of herpes virus saimiri-transformed human T lymphocytes.
J Exp Med. 1992 Sep 1;176(3):909-13. doi: 10.1084/jem.176.3.909.
本文引用的文献
1
Marrow-thymus interactions during radiation leukemogenesis in C57BL/Ka mice.
Cancer Res. 1981 Feb;41(2):390-2.
2
Nonimmunogenic radiation-induced lymphoma: immunity induction by a somatic cell hybrid.
J Natl Cancer Inst. 1982 May;68(5):841-9.
3
In vivo therapy of a murine B cell tumor (BCL1) using antibody-ricin A chain immunotoxins.
J Exp Med. 1982 Jun 1;155(6):1797-809. doi: 10.1084/jem.155.6.1797.
4
Monoclonal antibody to murine gamma interferon inhibits lymphokine-induced antiviral and macrophage tumoricidal activities.
J Exp Med. 1984 May 1;159(5):1560-5. doi: 10.1084/jem.159.5.1560.
5
The use of Cyclosporin A immunosuppression in organ grafting.
Immunol Rev. 1982;65:115-31. doi: 10.1111/j.1600-065x.1982.tb00430.x.
6
Antigen-specific murine T-cell lymphomas: functional heterogenicity.
Cell Immunol. 1981 Nov 15;65(1):194-200. doi: 10.1016/0008-8749(81)90064-2.
7
In vivo therapy of the BCL1 tumor: effect of immunotoxin valency and deglycosylation of the ricin A chain.
Cancer Res. 1988 May 1;48(9):2626-31.
8
Advances in human retroviruses.
Adv Cancer Res. 1988;51:307-60. doi: 10.1016/s0065-230x(08)60225-0.
9
Activation of interleukin 2 and interleukin 2 receptor (Tac) promoter expression by the trans-activator (tat) gene product of human T-cell leukemia virus, type I.
Proc Natl Acad Sci U S A. 1987 Aug;84(15):5389-93. doi: 10.1073/pnas.84.15.5389.
10
Direct activation of resting T lymphocytes by human T-lymphotropic virus type I.
Nature. 1987;326(6114):714-7. doi: 10.1038/326714a0.
Zotero 插件